- Home
- NAII vs TRIB Comparison
NAII vs TRIB Comparison
Compare NAII & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAII
- TRIB
- Stock Information
- Founded
- NAII 1980
- TRIB 1992
- Country
- NAII United States
- TRIB Ireland
- Employees
- NAII N/A
- TRIB N/A
- Industry
- NAII Medicinal Chemicals and Botanical Products
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NAII Health Care
- TRIB Health Care
- Exchange
- NAII Nasdaq
- TRIB Nasdaq
- Market Cap
- NAII 23.7M
- TRIB 25.5M
- IPO Year
- NAII 1987
- TRIB N/A
- Fundamental
- Price
- NAII $3.45
- TRIB $0.59
- Analyst Decision
- NAII
- TRIB
- Analyst Count
- NAII 0
- TRIB 0
- Target Price
- NAII N/A
- TRIB N/A
- AVG Volume (30 Days)
- NAII 10.2K
- TRIB 37.2K
- Earning Date
- NAII 05-13-2025
- TRIB 05-22-2025
- Dividend Yield
- NAII N/A
- TRIB N/A
- EPS Growth
- NAII N/A
- TRIB N/A
- EPS
- NAII N/A
- TRIB N/A
- Revenue
- NAII $121,853,000.00
- TRIB $59,126,000.00
- Revenue This Year
- NAII N/A
- TRIB $11.63
- Revenue Next Year
- NAII N/A
- TRIB $10.13
- P/E Ratio
- NAII N/A
- TRIB N/A
- Revenue Growth
- NAII N/A
- TRIB N/A
- 52 Week Low
- NAII $3.27
- TRIB $0.56
- 52 Week High
- NAII $7.26
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- NAII 41.39
- TRIB 36.73
- Support Level
- NAII $3.43
- TRIB $0.56
- Resistance Level
- NAII $3.62
- TRIB $0.71
- Average True Range (ATR)
- NAII 0.14
- TRIB 0.04
- MACD
- NAII 0.00
- TRIB -0.01
- Stochastic Oscillator
- NAII 4.08
- TRIB 15.62
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.